N-[2-chloro-5-(2-methyl-1,3-benzothiazol-5-yl)-3-pyridinyl]benzenesulfonamide | 1148008-32-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: N-[2-chloro-5-(2-methyl-1,3-benzothiazol-5-yl)-3-pyridinyl]benzenesulfonamide
• 英文别名: N-[2-chloro-5-(2-methyl-1,3-benzothiazol-5-yl)pyridin-3-yl]benzenesulfonamide
• CAS: 1148008-32-5
• 化学式: C₁₉H₁₄ClN₃O₂S₂
• 分子量: 415.924
• InChiKey: OVSZVZBGRLTEOK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  109
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] PYRIDOSULFONAMIDE DERIVATIVES AS PI3 KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDOSULFONAMIDE EN TANT QU'INHIBITEURS DE PI3 KINASE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009055418A1

  公开（公告）日：2009-04-30

  Invented is a method of inhibiting the activity/function of PB kinases using pyridosulfonamide derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of pyridosulfonamide derivatives.

  发明了一种使用吡啶磺酰胺衍生物抑制PB激酶活性/功能的方法。还发明了一种通过给予吡啶磺酰胺衍生物来治疗自身免疫性疾病、炎症性疾病、心血管疾病、神经退行性疾病、过敏、哮喘、胰腺炎、多器官功能衰竭、肾脏疾病、血小板聚集、癌症、精子活动力、移植排斥、移植物排斥和肺部损伤等一种或多种疾病状态的方法。
• PYRIDOSULFONAMIDE DERIVATIVES AS P13 KINASE INHIBITORS
  申请人：Adams Nicholas D.

  公开号：US20100311736A1

  公开（公告）日：2010-12-09

  Invented is a method of inhibiting the activity/function of PI3 kinases using pyridosulfonamide derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of pyridosulfonamide derivatives.

  本发明涉及使用吡啶磺酰胺衍生物抑制PI3激酶的活性/功能的方法。本发明还涉及使用吡啶磺酰胺衍生物治疗自身免疫性疾病、炎症性疾病、心血管疾病、神经退行性疾病、过敏、哮喘、胰腺炎、多器官衰竭、肾脏疾病、血小板聚集、癌症、精子运动能力、移植排斥、移植物排斥和肺损伤的方法。
• TETRAHYDROPYRIDINE CARBOXAMIDE DERIVATIVES AS TRPVL ANTAGONISTS
  申请人：Abbott Laboratories

  公开号：EP2185538A2

  公开（公告）日：2010-05-19
• PYRIDOSULFONAMIDE DERIVATIVES AS PI3 KINASE INHIBITORS
  申请人：GlaxoSmithKline LLC

  公开号：EP2211615A1

  公开（公告）日：2010-08-04
• [EN] AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS<br/>[FR] DÉRIVÉS AMIDES UTILISÉS COMME ANTAGONISTES DES TRPV1
  申请人：ABBOTT LAB

  公开号：WO2009023539A2

  公开（公告）日：2009-02-19

  The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, and R3, are defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.